Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process.

Russian-born technology businessman Yuri Milner, along with investors including Jeff Bezos, funded the company in 2021[1], operations started in 2022.

[2] The idea for Altos Labs originated with cell biologist and entrepreneur Richard D. Klausner, who co-founded the company with Hans Bishop.

[5] Milner had previously shown interest in anti-aging technologies, in October 2020, he co-hosted a meeting where experts presented their research, reported on animal testing, and the concept for Altos Labs was developed.

[2] In January 2022, the company's president, Hans Bishop, argued that Altos Labs was working on increasing the "healthspan" of humans and that longevity extension would only be "an accidental consequence".